BRCA-associated breast cancer during pregnancy

Bakhova L.A., Shevlyukova T.P., Keln A.A., Shvedsky M.S., Mateykovich E.A., Nekrasova O.V., Shkuratova V.V., Karmaeva O.S.

1) “Medical City” Multidisciplinary Clinical Medical Center, Tyumen, Russia; 2) Tyumen State Medical University, Ministry of Health of Russia, Tyumen, Russia

Background: Breast cancer (BC) is the most common breast form diagnosed during pregnancy (from 1:3,000 to 1:10,000 cases) and is about 3% of all forms of BC. Physiological changes during pregnancy can hide the early signs of BC and, thereby, delay the diagnosis. When planning treatment during pregnancy, in each case, it is inevitable to discuss the gestation period, stage and form of BC. Case report: The paper describes a clinical case of a 28-year-old pregnant woman with malignant breast neoplasm diagnosed at 9.1 weeks’ gestation, with a family history, BRCA1 gene mutation, and HER2neи amplification. Due to the patient's refusal to terminate the pregnancy, resection of the left breast with a nodular mass and biopsy of the sentinel lymph node biopsy were performed. A postoperative histological examination confirmed high-grade invasive ductal carcinoma; no metastases were found in the distant lymph nodes. A consultation of doctors recommended adjuvant chemotherapy according to the AS regimen with an inter-cycle drug administration period of 21 days and subsequent targeted therapy with trastuzumab after delivery. Conclusion: The discussed case reflects the complexities of diagnosis and combination treatment in pregnant patients with BC.

Authors' contributions: Bakhova L.A., Nekrasova O.V., Shkuratova V.V. – writing and designing the manuscript; Shevlyukova T.P., Mateykovich E.A. – editing the manuscript; Shvedsky M.S. – analyzing the literature sources; writing the manuscript; Keln A.A., Karmaeva O.S. – finally editing the manuscript.

Conflicts of interest: The authors declare that there are no conflicts of interest.

Funding: The investigation has not been sponsored.

Patient Consent for Publication: The female patient provided informed consent for the publication of their data and associated images.

For citation: Bakhova L.A., Shevlyukova T.P., Keln A.A., Shvedsky M.S., Mateykovich E.A., Nekrasova O.V., Shkuratova V.V., Karmaeva O.S. BRCA-associated breast cancer during pregnancy. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2023; (10): 199-203 (in Russian) https://dx.doi.org/10.18565/aig.2023.97

Keywords

breast cancer
pregnancy
diagnosis

References

  1. Parazzini F., Franchi M., Tavani A., Negri E., Peccatori F.A. Frequency of pregnancy related cancer: A population-based linkage study in Lombardy, Italy. Int. J. Gynecol. Cancer. 2017; 27(3): 613-9. https://dx.doi.org/10.1097/IGC.0000000000000904.
  2. Bae S.Y., Jung S.P., Jung E.S., Park S.M., Lee S.K., Yu J.H. et al. Clinical characteristics and prognosis of pregnancy- associated breast cancer: poor survival of luminal B subtype. Oncology. 2018; 95(3): 163-9. https://dx.doi.org/10.1159/000488944.
  3. Рассказова Е.А., Зикиряходжаев А.Д., Каприн А.Д. Лечение рака молочной железы на фоне беременности. Акушерство и гинекология. 2021; 10: 174-8. [Rasskazova E.A., Zikiryakhodzhaev A.D., Kaprin A.D. Treatment for breast cancer during pregnancy. Obstetrics and Gynecology. 2021; (10): 174-8. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.10.174-178.
  4. Пароконная А.А., Петровский А.В., Автомонов Д.Е., Сергеев Ю.С. Ошибки в диагностике рака молочной железы на фоне беременности и лактации на примере клинических случаев. Онкогинекология. 2021; 3: 17-23. [Parokonnaya A.A., Petrovsky A.V., Avtomonov D.E., Sergeev Yu.S. Errors in the diagnosis of breast cancer against the background of pregnancy and lactation on the example of clinical cases. Oncogynecology. 2021; (3): 17-23. (in Russian)].
  5. Шевлюкова Т.П., Бахова Л.А., Шведский М.С., Симонов А.В., Перымская А.С., Черная В.А. Изменение HER2-статуса на позитивный после неоадъювантной химиотерапии у пациентки с раком молочной железы. Женское здоровье и репродукция. 2023; 1: 64-8. [Shevlyukova T.P., Bahova L.A., Shvedsky M.S., Simonov A.V., Perymskaya A.S., Chernaya V.A. Change of HER2 status to positive after neoadjuvant chemotherapy in a patient with breast cancer. Women's Health and Reproduction. 2023; (1): 64-8. (in Russian)].
  6. Снежко О.А. Рак молочной железы и беременность. Главный врач Юга России. 2018; 4: 49-51. [Snezhko O.A. Breast cancer and pregnancy. Chief Physician of the South of Russia. 2018; (4): 49-51. (in Russian)].
  7. Шевлюкова Т.П., Бахова Л.А., Шведский М.С., Некрасова О.В., Шкуратова В.В., Федчук О.А. Эффективность неоадъювантной терапии в лечении больных местнораспространенным раком молочных желез. Доктор.Ру. 2023; 22(1): 28-32. [Shevlyukova T.P., Bahova L.A., Shvedsky M.S., Nekrasova O.V., Shkuratova V.V., Fedchuk O.A. The effectiveness of neoadjuvant therapy in the treatment of patients with locally advanced breast cancer. Doctor.Ru. 2023; 22(1): 28-32. (in Russian)]. https://dx.doi.org/10.31550/1727-2378-2023-22-1-28-32.
  8. Тилляшайхов М.Н., Шомансурова Н.С. Рак молочной железы и беременность. Клиническая и экспериментальная онкология. 2020; 1: 42-5. [Tillyashaykhov M.N., Shomansurova N.S. Breast cancer and pregnancy. Clinical and Experimental Oncology. 2020; (1): 42-5. (in Russian)].
  9. Доброхотова Ю.Э., Боровкова Е.И., Арутюнян А.М. Ассоциированный с беременностью рак молочной железы. Российский вестник акушера-гинеколога. 2019; 19(4): 77-81. [Dobrokhotova Iu.É., Borovkova E.I., Arutyunyan A.M. Pregnancy-associated breast cancer. Russian Bulletin of Obstetrician-Gynecologist. 2019; 19(4): 77 81. (in Russian)]. https://dx/doi.org/10.17116/rosakush20191904177.
  10. Доброхотова Ю.Э., Аракелов С.Э., Данелян С.Ж., Боровкова Е.И., Зыков А.Е., Залесская С.А., Нагайцева Е.А. Рак молочной железы, ассоциированный с беременностью: клинический случай. Гинекология. 2018; 20(1): 102-8. [Dobrokhotova Yu.E., Arakelov S.E., Danelyan S.Zh., Borovkova E.I., Zykov A.E., Zalesskaya S.A., Nagaytseva E.A. Breast cancer associated with pregnancy: a clinical case. Gynecology. 2018; 20(1): 102-8. (in Russian)]. https://dx.doi.org/10.26442/2079-5696_20.1.102-108.
  11. Петров Ю.А., Купина А.Д., Шаталов А.Е. Вероятность беременности и родов после рака молочной железы (обзор). Кубанский научный медицинский вестник. 2020; 27(5): 163-74. [Petrov Yu.A., Kupina A.D., Shatalov A.E. Pregnancy and labour likelihood after breast cancer (a review). Kuban Scientific Medical Bulletin. 2020; 27(5): 163-74. (in Russian)]. https://dx.doi.org/10.25207/1608-6228-2020-27-5-163-174.
  12. Обоскалова Т.А., Коваль М.В., Севостьянова О.Ю. Опыт персонифицированной тактики ведения пациенток с раком молочной железы, ассоциированным с беременностью. Пермский медицинский журнал. 2023; 40(2): 123-30. [Oboskalova T.A., Koval M.V., Sevostyanova O.Yu. Experience of personalized tactics of management of patients with breast cancer associated with pregnancy. Perm Medical Journal. 2023; 40(2): 123-30. (in Russian)].
  13. Андреева Н.Л. Рак молочной железы и беременность. Медицинские новости. 2019; 5: 4-8. [Andreyeva N.L. Breast cancer and pregnancy. Medical News. 2019; (5): 4-8. (in Russian)].
  14. Тер-Ованесов М.Д., Шаль Е.П., Кукош М.Ю., Оганисян А.Н. Рак молочной железы, ассоциированный с беременностью: диагностика, лечение, прогноз. Медицинский алфавит. 2018; 2(29): 10-6. [Ter-Ovanesov M.D., Shal E.P., Kukosh M.Yu., Oganesyan A.N. Breast cancer associated with pregnancy: diagnosis, treatment, prognosis. Medical Alphabet. 2018; 2(29): 10-6. (in Russian)].

Received 13.04.2023

Accepted 09.06.2023

About the Authors

Lilia A. Bakhova, Senior Lecturer, Department of Oncology, Radiology and Radiotherapy, Institute of Clinical Medicine, Tyumen State Medical University,
Ministry of Health of Russia, lilya8913@mail.ru, eLibrary.Ru SPIN: 8832-3547, https://orcid.org/0000-0002-8918-6264, 625041, Russia, Tyumen, Barnaulskaya str., 32a.
Tatiana P. Shevlyukova, Dr. Med. Sci., Professor, Department of Obstetrics and Gynecology, Institute of Maternity and Childhood, Tyumen State Medical University,
Ministry of Health of Russia, tata21.01@mail.ru, eLibrary.Ru SPIN: 5035-7233, https://orcid.org/0000-0002-7019-6630, 625023, Russia, Tyumen, Odesskaya str., 54.
Artem A. Keln, PhD, Associate Professor, Department of Oncology, Radiology and Radiotherapy, Institute of Clinical Medicine, Tyumen State Medical University,
Ministry of Health of Russia, Artyom-keln@yandex.ru, eLibrary.Ru SPIN: 9633-0276, https://orcid.org/0000-0002-5071-0604, 625023, Russia, Tyumen, Odesskaya str., 54.
Maxim S. Shvedsky, 6th year student, Institute of Clinical Medicine, Tyumen State Medical University, Ministry of Health of Russia, Shvedsky99@gmail.com,
eLibrary.Ru SPIN: 2797-1965, https://orcid.org/0000-0002-8854-2773, 625023, Russia, Tyumen, Odesskaya str., 54.
Elena A. Mateykovich, PhD, Associate Professor, Department of Obstetrics and Gynecology, Director of the Institute of Maternity and Childhood, Tyumen State Medical University, Ministry of Health of Russia, mat-maxim@yandex.ru, eLibrary.Ru SPIN: 5864-8031, AuthorID: 744233, https://orcid.org/0000-0002-2612-7339,
625023, Russia, Tyumen, Odesskaya str., 54.
Oksana V. Nekrasova, Head of OPLT Department No. 2, ICMC Medical City, kuban.ksu@mail.ru, 32a Barnaulskaya St., Tyumen, 625032, Russia.
Vlada V. Shkuratova, doctor, OPLT No. 2, ICMC "Medical City", shkuratovavv@mail.ru, 625032, Russia, Tyumen, Barnaulskaya str., 32a.
Olga S. Karmaeva, Head of the Department of Molecular Genetics and Oncochemistry, Pathology Bureau, ICMC "Medical City", oskormina@mail.ru,
625032, Russia, Tyumen, Yury Semovskikh str., 12.
Corresponding author: Maxim S. Shvedsky, Shvedsky99@gmail.com

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.